The rationale for recommending fixed-dose …
The rationale for recommending fixed-dose combination tablets for treatmentof tuberculosis Bjørn Blomberg,1 Sergio Spinaci,2 Bernard Fourie,3 & Richard Laing4 There is considerable exigency to take all necessary steps to cure tuberculosis cases and prevent further emergence
Download The rationale for recommending fixed-dose …
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
ACG Clinical Guideline: The Diagnosis and …
gi.orgThe American Journal of GASTROENTEROLOGY VOLUME 104 | XXX 2014 www.amjgastro.com 2 Chalasani et al. data have begun to blur the distinction between these two catego-ries somewhat, they remain useful conceptual paradigms. APAP,
DRUGS TO AVOID IN G6PD DEFICIENCY - cych.org.tw
www.cych.org.twDRUGS TO AVOID IN G6PD DEFICIENCY DEFINITE RISK OF HAEMOLYSIS POSSIBLE RISK OF HAEMOLYSIS Pharmacological Class Drugs* Pharmacological Class Drugs* • ß-Naphthol
ANXIETY DISORDER MEDICATION Generic/TRADE …
drofrx.comANXIETY DISORDER MEDICATION Comparison Chart www.RxFiles.ca Brent Jensen BSP Sept 04 Generic/TRADE Class Side effects (SE) Anxiolytic Uses 1,2,3,4 Comments ( = therapeutic use) INITIAL & MAX DOSE USUAL …
Guidelines for the Management of Adverse Drug …
www.uphs.upenn.edu2 Drug Used in the Treatment of Tuberculosis First Line Drugs Generic Name Trade Name isoniazid (INH) Laniazid®, Nydrazid® rifampin Rifadin ®, Rimactane® rifapentine Priftin®
Drug-induced rhabdomyolysis
www.charlydmiller.comDrug-induced rhabdomyolysis Teresa J. Coco and Ann E. Klasner Purpose of review Drug-induced rhabdomyolysis is a common syndrome that …
Table 1: Medications that influence warfarin therapy
www.silkview.comMedications that influence warfarin therapy Significant increase in the INR Significant decrease in the INR Amiodarone Amobarbital Anabolic steroids Aprepitant Bactrim (TMP/SMZ) Butabarbital Chloramphenicol Carbamazepine Disulfiram Dicloxacillin Fluconazole Griseofulvin Isoniazid Methimazole Metronidazole Phenobarbital …
減感作により再投与可能となったIsoniazidによる …
www.jrs.or.jpはじめに 結核の治療は多剤併用が原則であり，副作用もしばし ば経験される．特にisoniazid（INH）やrifampicin（RFP）
Fixed-dose combinations for the treatment of TB in …
www.who.intABOUT THE FIXED-DOSE COMBINATIONS FOR CHILDREN The formulations available are : For the intensive phase of TB treatment: Rifampicin 75 mg + Isoniazid 50 mg +